SKI Market

A+| A| A-|

Indian Indices

Sensex

77,409.98 254.36
( 0.33%)

Global Indices

Nasdaq

51,515.27 -505.40
(-0.97%)

Dow Jones

7,441.22 -91.13
(-1.21%)

Hang Seng

71,050.31 1,148.06
(1.64%)

Nikkei 225

10,505.62 11.41
(0.11%)

Forex

USD-INR

94.55 -0.09
(-0.09%)

EUR-INR

109.66 -0.13
(-0.12%)

GBP-INR

126.84 -0.25
(-0.20%)

JPY-INR

0.59 0.00
(-0.20%)

YOU ARE HERE :
HOME
Markets
Equity
Company News Details

EQUITY - MARKET SCREENER

ERIS Lifesciences Ltd

Industry : Pharmaceuticals - Indian - Formulations

BSE Code

ISIN Demat

Book Value()

540596

INE406M01024

230.6075957

NSE Symbol

P/E(TTM)

Mar.Cap( Cr.)

ERIS

76.93

19540.76

EPS(TTM)

Face Value()

Div & Yield %

18.33

0.51

Back

Dhanalaxmi Roto Spinners standalone net profit declines 34.54% in the December 2025 quarter

Feb 11,2026

Net profit of Dhanalaxmi Roto Spinners declined 34.54% to Rs 1.63 crore in the quarter ended December 2025 as against Rs 2.49 crore during the previous quarter ended December 2024. Sales declined 19.74% to Rs 55.28 crore in the quarter ended December 2025 as against Rs 68.88 crore during the previous quarter ended December 2024.

Particulars	Quarter Ended
	Dec. 2025	Dec. 2024	% Var.
Sales	55.28	68.88	-20
OPM %	1.52	4.69	-
PBDT	1.99	3.56	-44
PBT	1.93	3.48	-45
NP	1.63	2.49	-35

77,409.98 254.36 ( 0.33%)

51,515.27 -505.40 (-0.97%)

7,441.22 -91.13 (-1.21%)

71,050.31 1,148.06 (1.64%)

10,505.62 11.41 (0.11%)

94.55 -0.09 (-0.09%)

109.66 -0.13 (-0.12%)

126.84 -0.25 (-0.20%)

0.59 0.00 (-0.20%)